Futura Medical (LON:FUM) Sets New 12-Month Low – Here’s Why

Futura Medical plc (LON:FUM)’s share price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 21.50 ($0.27) and last traded at GBX 33.30 ($0.42), with a volume of 10440612 shares traded. The stock had previously closed at GBX 33.68 ($0.43).

Futura Medical Stock Performance

The company has a market capitalization of £99.31 million, a price-to-earnings ratio of -3,300.00 and a beta of 1.25. The company has a 50-day moving average price of GBX 34.79 and a 200-day moving average price of GBX 35.85.

Insider Transactions at Futura Medical

In related news, insider James Henry Barder sold 250,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of GBX 41 ($0.52), for a total value of £102,500 ($130,109.16). Corporate insiders own 32.14% of the company’s stock.

Futura Medical Company Profile

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.